A phase II study of pemetrexed and gemcitabine plus bevacizumab as first line chemotherapy for elderly patients with stage IIIB/IV non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Bevacizumab (Primary) ; Gemcitabine (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 21 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2010 Planned end date changed from 1 Feb 2009 to 1 May 2010 as reported by ClinicalTrials.gov.